Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nitschmann

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
Der Internist|July 31, 2008
[ Therapy of patients at high risk for vascular events: telmisartan, ramipril or a combination? ]R Düsing, S Nitschmann
Der Internist|May 24, 2017
[Cardiovascular safety of celecoxib : Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen (PRECISION)]K Schrör, S Nitschmann
Der Internist|April 6, 2018
[Cardiovascular outcomes for people using anticoagulation strategies : COMPASS]M Moser, S Nitschmann
Der Internist|January 13, 2009
[Therapeutic aims for atrial fibrillation in patients with heart failure]T Lewalter, S Nitschmann
Der Internist|April 8, 2009
[Therapy of rheumatoid arthritis with etanercept]P Lamprecht, S Nitschmann
Der Internist|May 1, 2009
[New agents for the prevention of venous thromboembolism]J Harenberg, S Nitschmann
Der Internist|June 15, 2010
[Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)]P Mallmann, S Nitschmann
Der Internist|April 16, 2014
[Mediterranean diet for primary prevention of cardiovascular diseases : Prevención-con-Dieta-Mediterránea (PREDIMED) Study]W Krone, S Nitschmann
Der Internist|August 9, 2015
[Step-by-step toward the perfect hepatitis C treatment for all genotypes]M Cornberg, S Nitschmann
Der Internist|October 9, 2015
[Smoking: Cardiovascular effects and abstinence strategies]N Suttorp, S Nitschmann
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
Der Internist|July 31, 2008
[ Therapy of patients at high risk for vascular events: telmisartan, ramipril or a combination? ]R Düsing, S Nitschmann
Der Internist|May 24, 2017
[Cardiovascular safety of celecoxib : Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen (PRECISION)]K Schrör, S Nitschmann
Der Internist|April 6, 2018
[Cardiovascular outcomes for people using anticoagulation strategies : COMPASS]M Moser, S Nitschmann
Der Internist|January 13, 2009
[Therapeutic aims for atrial fibrillation in patients with heart failure]T Lewalter, S Nitschmann
Der Internist|April 8, 2009
[Therapy of rheumatoid arthritis with etanercept]P Lamprecht, S Nitschmann
Der Internist|May 1, 2009
[New agents for the prevention of venous thromboembolism]J Harenberg, S Nitschmann
Der Internist|June 15, 2010
[Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)]P Mallmann, S Nitschmann
Der Internist|April 16, 2014
[Mediterranean diet for primary prevention of cardiovascular diseases : Prevención-con-Dieta-Mediterránea (PREDIMED) Study]W Krone, S Nitschmann
Der Internist|August 9, 2015
[Step-by-step toward the perfect hepatitis C treatment for all genotypes]M Cornberg, S Nitschmann
Der Internist|October 9, 2015
[Smoking: Cardiovascular effects and abstinence strategies]N Suttorp, S Nitschmann
Pageof 23